Home › Funds › Samsara BioCapital, LLC › IVA

Samsara BioCapital, LLC position in IVA

INVENTIVA SA · Health Care

Samsara BioCapital, LLC reported holding 6,314,805 shares of IVA (INVENTIVA SA) in its Q2 2026 13F filing — a position valued at US$23.9M, representing 1.96% of its reported portfolio and ranking #10 among its reported holdings. Samsara BioCapital, LLC has disclosed IVA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)6.31M sh
Reported value held$23.87M
Portfolio Weight1.96%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Samsara BioCapital, LLC's IVA position evolved

Samsara BioCapital, LLC first disclosed a stake in IVA in Q4 2025 at 5,194,805 shares (US$24.2M). The position peaked in Q1 2026 at 5,194,805 shares, worth US$28.8M. Across 3 filings, Samsara BioCapital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 6,314,805 shares valued at US$23.9M — an increase of 1,120,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 5.19M $24.16M New
Q1 2026 5.19M $28.83M Hold
Q2 2026 6.31M $23.87M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IVA and 13F data

IVA (INVENTIVA SA) is a Health Care company. 94 other funds we track also report a position in IVA — the largest reported positions include Caligan Partners LP (US$30.9M), Paradigm Biocapital Advisors LP (US$15.1M), ADAR1 Capital Management, LLC (US$13.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IVA

All IVA fund holders →

FAQ

How long has Samsara BioCapital, LLC held IVA?

Samsara BioCapital, LLC has disclosed IVA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Samsara BioCapital, LLC's current position in IVA?

As of Q2 2026, Samsara BioCapital, LLC holds 6.31M shares of IVA (INVENTIVA SA), valued at $23.87M, representing 1.96% of its reported portfolio and ranking #10.

Has Samsara BioCapital, LLC been buying or selling IVA?

In the latest 13F filing (Q2 2026), Samsara BioCapital, LLC increased its position in IVA. The position peaked in Q1 2026 at 5.19M shares.

Which other funds hold IVA?

Other major institutional holders of IVA include Caligan Partners LP, Paradigm Biocapital Advisors LP, ADAR1 Capital Management, LLC, among 94 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.